EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Glycan Profiling in Small Extracellular Vesicles with a SERS Microfluidic Biosensor Identifies Early Malignant Development in Lung Cancer

Quan Zhou iD, Xueming Niu, Zhen Zhang, Kenneth O'Byrne, Arutha Kulasinghe, David Fielding, Andreas Möller, Alain Wuethrich iD, Richard J Lobb iD, Matt Trau iD

Advanced Science · 2024

DOI: 10.1002/advs.202401818 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Advanced Science, 2024. Verfasst von Quan Zhou und 9 weiteren Autor:innen. Beteiligte Einrichtung: Centre for Personalised Nanomedicine, Australian Institute for Bioengineering and Nanotechnology (AIBN), The University of Queensland, Brisbane, QLD,…. Hauptthemen laut MEDLINE: Extracellular Vesicles, Lung Neoplasms, Spectrum Analysis, Raman, Polysaccharides. Die Arbeit wurde bisher 39-mal zitiert (Crossref) und nennt 63 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Health and Medical Research Council, China Scholarship Council, Australian Research Council.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Glycosylation is the most common post‐translational modification of proteins and regulates a myriad of fundamental biological processes under normal, and pathological conditions. Altered protein glycosylation is linked to malignant transformation, showing distinct glycopatterns that are associated with cancer initiation and progression by regulating tumor proliferation, invasion, metastasis, and therapeutic resistance. The glycopatterns of small extracellular vesicles (sEVs) released by cancer cells are promising candidates for cancer monitoring since they exhibit glycopatterns similar to their cell‐of‐origin. However, the clinical application of sEV glycans is challenging due to the limitations of current analytical technologies in tracking the trace amounts of sEVs specifically derived from tumors in circulation. Herein, a sEV GLYcan PHenotype (EV‐GLYPH) assay that utilizes a microfluidic platform integrated with surface‐enhanced Raman scattering for multiplex profiling of sEV glycans in non‐small cell lung cancer is clinically validated. For the first time, the EV‐GLYPH assay effectively identifies distinct sEV glycan signatures between non‐transformed and malignantly transformed lung cells. In a clinical study evaluated on 40 patients, the EV‐GLYPH assay successfully differentiates patients with early‐stage malignant lung nodules from benign lung nodules. These results reveal the potential to profile sEV glycans for noninvasive diagnostics and prognostics, opening up promising avenues for clinical applications and understanding the role of sEV glycosylation in lung cancer.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Extracellular VesiclesLung NeoplasmsSpectrum Analysis, RamanPolysaccharidesHumansBiosensing TechniquesMicrofluidicsGlycosylationCarcinoma, Non-Small-Cell LungFemaleMale

Stichwörter der Autor:innen

early diagnosisextracellular vesiclesglycosylationliquid biopsiesminiaturized biosensorsnon‐small cell lung cancersurface‐enhanced Raman spectroscopy

Substanzen

Polysaccharides

Autor:innen und Institutionen

  • Centre for Personalised Nanomedicine, Australian Institute for Bioengineering and Nanotechnology (AIBN), The University of Queensland, Brisbane, QLD, 4072, Australia.
  • School of Biomedical Sciences, Queensland University of Technology, Brisbane, QLD, 4102, Australia.
  • Frazer Institute, Faculty of Medicine, The University of Queensland, Brisbane, QLD, 4102, Australia.
  • Department of Thoracic Medicine, Royal Brisbane and Women's Hospital, Brisbane, QLD, 4029, Australia.
  • JC STEM Lab, Li Ka Shing Institute of Health Sciences, Department of Otorhinolaryngology, Faculty of Medicine, Chinese University of Hong Kong, Shatin, Hong Kong SAR, 999077, China.
  • Tumour Microenvironment Laboratory, QIMR Berghofer Medical Research Institute, Brisbane, QLD, 4029, Australia.

ORCID-Profile: Quan Zhou, Alain Wuethrich, Richard J Lobb, Matt Trau

Förderung

  • National Health and Medical Research Council
  • China Scholarship Council
  • Australian Research Council
  • Cancer Council Queensland
  • Innovation and Technology Commission, Hong Kong SAR
  • Hong Kong Jockey Club Charities Trust
  • Cancer Council Australia

Zitieren

APA

Zhou, Q., Niu, X., Zhang, Z., O'Byrne, K., Kulasinghe, A., Fielding, D., Möller, A., Wuethrich, A., Lobb, R. J., & Trau, M. (2024). Glycan Profiling in Small Extracellular Vesicles with a SERS Microfluidic Biosensor Identifies Early Malignant Development in Lung Cancer. Advanced Science. https://doi.org/10.1002/advs.202401818

Vancouver

Zhou Q, Niu X, Zhang Z, O'Byrne K, Kulasinghe A, Fielding D, et al. Glycan Profiling in Small Extracellular Vesicles with a SERS Microfluidic Biosensor Identifies Early Malignant Development in Lung Cancer. Advanced Science. 2024. doi:10.1002/advs.202401818

BibTeX
@article{Zhou2024,
  author = {Zhou, Quan and Niu, Xueming and Zhang, Zhen and O'Byrne, Kenneth and Kulasinghe, Arutha and Fielding, David and Möller, Andreas and Wuethrich, Alain and Lobb, Richard J and Trau, Matt},
  title = {Glycan Profiling in Small Extracellular Vesicles with a SERS Microfluidic Biosensor Identifies Early Malignant Development in Lung Cancer},
  journal = {Advanced Science},
  year = {2024},
  doi = {10.1002/advs.202401818}
}
Kostenlos starten →